Trial Outcomes & Findings for MRI of Infrapatellar Fat Pad in Osteoarthritis (NCT NCT02829463)
NCT ID: NCT02829463
Last Updated: 2017-06-12
Results Overview
Recruitment status
COMPLETED
Target enrollment
121 participants
Primary outcome timeframe
collect the data within 24 hours after the subjects did the MRI
Results posted on
2017-06-12
Participant Flow
Participant milestones
| Measure |
Osteoarthritis Patients
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
Healthy Controls
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
|---|---|---|
|
Overall Study
STARTED
|
59
|
62
|
|
Overall Study
COMPLETED
|
59
|
62
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
MRI of Infrapatellar Fat Pad in Osteoarthritis
Baseline characteristics by cohort
| Measure |
Osteoarthritis Patients
n=59 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
Healthy Controls
n=62 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
Total
n=121 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.6 years
STANDARD_DEVIATION 9.2 • n=5 Participants
|
38.8 years
STANDARD_DEVIATION 13.6 • n=7 Participants
|
49.9 years
STANDARD_DEVIATION 15.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
36 Participants
n=5 Participants
|
29 Participants
n=7 Participants
|
65 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
23 Participants
n=5 Participants
|
33 Participants
n=7 Participants
|
56 Participants
n=5 Participants
|
|
BMI
|
24.7 kg/(m^2)
STANDARD_DEVIATION 3.5 • n=5 Participants
|
22.6 kg/(m^2)
STANDARD_DEVIATION 4.4 • n=7 Participants
|
23.6 kg/(m^2)
STANDARD_DEVIATION 4.1 • n=5 Participants
|
PRIMARY outcome
Timeframe: collect the data within 24 hours after the subjects did the MRIOutcome measures
| Measure |
Osteoarthritis Patients
n=59 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
Healthy Controls
n=62 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands.
Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
|
|---|---|---|
|
Infrapatellar Fat Pad Volume in MRI
|
25154.96 mm^3
Standard Deviation 4865.37
|
29202.39 mm^3
Standard Deviation 7242.63
|
Adverse Events
Osteoarthritis Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Healthy Controls
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Jinshen He
Third Xiangya Hospital of Central South University
Phone: 8613517470997
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place